Skip to main content

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) Investor Securities Class Action Lawsuit 07/31/2023

  • If you purchased a significant amount of shares of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between March 17, 2022 and June 20, 2023, and / or if you purchased any NASDAQ: ALDX shares prior to March 2022 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: September 29, 2023. NASDAQ: ALDX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 2, 2024 - An amended consolidated complaint was filed. July 31, 2023 - An investor in shares of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Aldeyra Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between M...

You must register (for free) or login to view the entire case.